-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preoperative-testing_executive.pdf
January 01, 2014 - 1
Comparative Effectiveness Review
Number 130
Benefits and Harms of Routine Preoperative
Testing: Comparative Effectiveness
Executive Summary
Introduction
Traditionally, preoperative testing has been
part of the preoperative care process to
inform patient selection by determining
fitness for anesthesia and ide…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
March 01, 2012 - 1
Comparative Effectiveness Review
Number 53
Treatment To Prevent Fractures in Men
and Women With Low Bone Density or
Osteoporosis: Update of a 2007 Report
Executive Summary
Background
Osteoporosis is a systemic skeletal disease
characterized by decreasing bone mass and
microarchitectural deterioration of bo…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - 1
Comparative Effectiveness Review
Number 108
Migraine in Children:
Preventive Pharmacologic Treatments
Executive Summary
Introduction
The Agency for Healthcare Research
and Quality (AHRQ) commissioned the
Minnesota Evidence-based Practice
Center (EPC) to conduct a review of
preventive pharmacologic treatm…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
January 01, 2020 - 1
Comparative Effectiveness Review
Number 97
Strategies To Prevent Weight Gain
Among Adults
Executive Summary
Background
Condition
One of the Healthy People 2020 national
objectives is to increase the prevalence
of a healthy weight among adults to
34 percent and to reduce the prevalence
of obesity amon…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
October 01, 2010 - Layout 1
Background
Cystic fibrosis (CF) is the second most
common life-shortening, childhood-onset
genetic disease in the United States,
affecting approximately 30,000 people in
the Nation. The gene responsible for CF
encodes the cystic fibrosis transmembrane
regulator (CFTR) protein, which regulates
sodium and chl…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
June 22, 2017 - Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Venous Thromboembolism Prophylaxis in Major Orthopedic
Surgery: Systematic Review Update
Draft review available for public com…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
October 01, 2016 - providing model-generated output (e.g., incidence rates, mortality rates,
distributions of patients across stages
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
July 10, 2012 - However, we
explored the wording and order of questions in
great detail during the early stages of
-
effectivehealthcare-admin.ahrq.gov/products/smoking-pregnancy-infants/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
March 21, 2016 - Disposition of Comments for CER 165 Fecal Incontinence
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Treatments for Fecal Incontinence
Draft review available for public comment from June 1, 2015 to June 29, 2015.
Research Review Citation: Forte ML, Andrade KE, Butler M, …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
January 01, 2017 - Appendix E-2
Appendix E-2. Data Abstraction of Outcomes
Table E-2-1
Table E-2-1. Outcomes from RCTs addressing Key Question 1
Author, Year
Country
Quality Rating Interventions Primary Effectiveness Outcomes Secondary Effectiveness Outcomes Primary Fetal Harms Outcomes Secondary Fetal Harms…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
September 01, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Nonpharmacologic Interventions for Treatment-Resistant
Depression in Adults
Draft review avail…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ankyloglossia_disposition-comments.pdf
May 04, 2015 - Disposition of Comments Report for Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie
Draft review available for public comme…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
June 30, 2015 - Disposition of Comments for Technical Brief 23 Genetic Testing
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Genetic Testing for Developmental Disabilities, Intellectual
Disability, and Autism Spectrum Disorder
Draft review available for public comment from Dec…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/celiac-disease_executive.pdf
January 01, 2016 - 1
Comparative Effectiveness Review
Number 162
Diagnosis of Celiac Disease
Executive Summary
Background
Condition
Celiac disease (CD) is an immune-
mediated disorder triggered in genetically
susceptible individuals by ingestion of
foods containing gluten, a family of
proteins found in wheat, rye, barley, and
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States
Evidence-based Practice Center Systematic Review Protocol
Project Title: Safety of Vaccines Used for Routine Immunization in the United States
I. Background and Objectives for the Systematic Review
Vaccines are consi…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
April 01, 2014 - 1
Comparative Effectiveness Review
Number 128
Oral Mechanical Bowel Preparation
for Colorectal Surgery
Executive Summary
Background
In the United States, oral mechanical
bowel preparation (OMBP), defined
as the use of an oral preparation given
prior to surgery to clear fecal material
from the bowel lumen,…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
December 31, 2022 - Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review
Rapid Evidence Product
Version 3.0 (July 2022)
Antibody Response Following SARS-CoV-2
Infection and Implications for Immunity: Final
Update of a Rapid, Living Review
What Di…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
April 01, 2014 - Methods Research Report
Use of Evidence-Based Practice Center
Comparative Effectiveness Reviews by Clinical
Point-of-Care Tools
Methods Research Report
Use of Evidence-Based Practice Center Comparative
Effectiveness Reviews by Clinical Point-of-Care Tools
Prepared for:
Agency for Healthcare Research…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
December 01, 2017 - Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin - Executive Summary
Comparative Effectiveness Review
Number 199
Treatments for Basal Cell and Squamous Cell Carcinoma
of the Skin
Evidence Summary
Introduction
Skin cancers, including basal cell
carcinoma (BCC) and squamous cell
carcinoma (SCC),…